Renovion
First Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1 in Lung Transplant
Source | Business Wire April 18, 2023 08:52 AM Eastern Daylight Time CHAPEL HILL, N.C - Renovion, Inc. today announced that the first...
top of page
News
Search
Renovion
- Apr 3
- 1 min
Double breath of fresh air for Triangle startup: $15M in new cash, fast track status for treatment
Startup Renovion, its marketing slogan “Restoring Lung Health One Breath at a Time,” has gotten two doses of fresh air for its treatment eff
Renovion
- Mar 30
- 2 min
Renovion Receives FDA Fast Track Designation for ARINA-1 for the Prevention of BOS Progression in LT
The Fast Track designation accelerates the FDA regulatory path for ARINA-1 for the prevention of bronchiolitis obliterans syndrome (BOS)...
Renovion
- Nov 2, 2022
- 3 min
First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE
Renovion and COPD Foundation Joint Release – Renovion, Inc. has announced that the first patient has been enrolled in a Phase 2 clinical...
Renovion
- Aug 2, 2022
- 2 min
Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for serious chronic inflammatory lung diseases...
Renovion
- Apr 12, 2022
- 3 min
Marty Zamora, MD, joins Renovion, Inc. as Chief Medical Officer
Renovion today announced that Dr. Martin “Marty” Zamora, MD, has joined Renovion as Chief Medical Officer. Dr. Zamora will lead the Phase...
Renovion
- Apr 7, 2022
- 2 min
Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases...
Renovion
- Nov 18, 2021
- 6 min
A breathe-easier breakthrough
Renovion, a UNC-affiliated startup, advances a breakthrough therapy to restore lung health and quality of life in patients with diseases...
Renovion
- Nov 8, 2021
- 3 min
Exploristics signs collaboration agreement with Renovion, using the cloud-based simulation platform
Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform...
bottom of page